Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × talquetamab × Clear all

NCT04634552 2026-06-05

MonumenTAL-1

Phase 2 Recruiting

510 enrolled 1 FDA

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms